Učitavanje...
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies
Fluoropyrimidines form the mainstay in treatment of gastrointestinal malignancies. For decades 5-fluorouracil (5FU), was the major fluoropyrimidine. Currently it is usually given in a combination with leucovorin and oxaliplatin, i.e. FOLFOX, or irinotecan, i.e. FOLFIRI, or all three, i.e. FOLFIRINOX...
Spremljeno u:
| Izdano u: | Ther Adv Med Oncol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622302/ https://ncbi.nlm.nih.gov/pubmed/26557901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015603313 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|